ImmuCell CorporationICCCNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank86
3Y CAGR-0.5%
5Y CAGR+3.5%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
-0.5%/yr
vs +7.9%/yr prior
5Y CAGR
+3.5%/yr
Recent deceleration
Acceleration
-8.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$9.80M+2.2%
2024$9.58M-5.6%
2023$10.14M+2.0%
2022$9.95M+18.4%
2021$8.40M+1.9%
2020$8.24M+7.1%
2019$7.69M+4.8%
2018$7.34M+34.4%
2017$5.46M+20.6%
2016$4.53M-